• Cyclin-D1 (BCL1) Expression, Immunohistochemistry, Tissue
  • Post-transplant Test for Kidney Acute Rejection (VitaGraft™, Tuteva™)
  • Retinal Detachment
  • Hepatitis C Virus (HCV) by Molecular Method, Qualitative or Quantitative
  • Serotonin Receptor HTR2A Genotyping
  • Malignant neoplasm of pharynx
  • Malignant neoplasm of parathyroid gland (parathyroid carcinoma)
  • Acute intermittent porphyria
  • Sertraline, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Endometrial Carcinoma Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Endometrial Carcinoma Gene Mutation Panel, NGS
Medical Test

Methodology
Access to Endometrial Carcinoma Gene Mutation Panel, NGS is restricted.
Loading...